Mandangan, Maybel .
HRN: 25-18-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CEFUROXIME 500MG (TAB)
06/14/2024
06/20/2024
PO
1 Tab
BID X 7 Days
S/p NSVD, Thinly MSAF, RMLE With Episioraphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes